Moneycontrol > News > Astrology

Sep 20, 2012, 09.43 AM IST

Dr Reddy, Sun Pharma to get astro support: Satish Gupta

Pharma stocks like Dr Reddy, Divis Lab, Sun Pharma, Biocon and Ranbaxy will be getting astrological support, says Satish Gupta of Astrostocktips.

Source: Moneycontrol.com
Share Share on Tumblr
Share  .  Email  .  Print  .  A+
By Satish Gupta of Astrostocktips


Today's planetary position: Moon will be transiting in Libra, Lord Saturn & Mars in Libra. Jupiter & Ketu in Taurus. Venus in Cancer, Sun & Mercury in Virgo, Rahu in Scorpio. Pluto in Sagittarius, Uranus in Pisces. Neptune in Aquarius.


RAHU KAL TIME: 13.30-15.00


Following sector will be getting astrological support:


Pharma: Dr Reddy , Divis Lab , Sun Pharma , Biocon and Ranbaxy .


It has been observed many times that investors / traders (not knowing this fact) keep investing /trading in such sectors,( whose astrological support is over) resulting in  losses. It is suggested to consult your Financial Astrologer to know about the sectors.


One should trade only in the stocks of that sectors which are getting very strong astrologically support, since the chances of losing money in such stocks are very less.


Sectors which get strong ASTRO support are not normally affected by downfall in the market.


Although we predict sectors, it is not necessary that all stocks with in same sector should move up same day.


Disclaimer: The views and investment tips expressed by investment experts/astrologers on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.


Indian quartet lauded by MIT for new gesture-recognition system
IPL spot-fixing: What's Sakshi Dhoni got to do with it? "IPL spot-fixing: What's Sakshi Dhoni got to do with it?"

From DJ EU Officials Spain Aid Cap Of 100 Bn Euros 'should Be Enough'

The latest earning numbers FIRST on CNBC-TV18
News Videos

May 22 2013, 13:11

Nifty to consolidate; go long above 6200: ICICI Direct

- in MARKET OUTLOOK